Leap Therapeutics Inc. (LPTX)
NASDAQ: LPTX
· Real-Time Price · USD
0.40
-0.01 (-2.91%)
At close: May 16, 2025, 3:59 PM
0.39
-2.55%
After-hours: May 16, 2025, 06:31 PM EDT
Leap Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|
| License Revenue | 1.5M | 1.5M |
| License Revenue Growth | 0.00% | n/a |
| Royalty Revenue | n/a | n/a |
| Royalty Revenue Growth | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.01M | 3.01M | 2.94M | 3.37M | 3.53M | 3.02M | 3.33M | 3.56M | 3.78M | 2.91M | 3.19M | 2.85M | 2.85M | 2.79M | 2.44M | 2.79M | 2.74M | 2.43M | 2.51M | 2.52M | 2.15M | 2.6M | 2.15M | 2.33M | 2M | 2.06M | 2.14M | 2.6M | 2.11M | 2.13M | 1.78M | 2.13M | 3.8M | 734K | 1.37M | 1.07M | 1.06M | 604K | 1.57M | 1.93M | 1.61M |
| Selling, General, and Administrative Revenue Growth | -0.23% | +2.48% | -12.68% | -4.51% | +16.56% | -9.16% | -6.41% | -5.97% | +30.08% | -8.69% | +11.59% | +0.25% | +1.97% | +14.56% | -12.77% | +2.01% | +12.85% | -3.42% | -0.28% | +17.09% | -17.32% | +21.06% | -7.48% | +15.96% | -2.81% | -3.69% | -17.71% | +23.19% | -0.80% | +19.66% | -16.63% | -43.87% | +418.26% | -46.38% | +27.94% | +1.33% | +74.83% | -61.58% | -18.63% | +19.85% | n/a |
| Research and Development Revenue | 12.91M | 13.11M | 14.91M | 17.89M | 11.3M | 11.69M | 11.5M | 11.1M | 38.94M | 11.03M | 12.1M | 14.04M | 7.78M | 8.07M | 10.08M | 7.21M | 6.81M | 5.1M | 5.37M | 5.35M | 4.6M | 5.67M | 5.77M | 6.14M | 6.79M | 7.34M | 6.16M | 3.99M | 3.58M | 4.42M | 6.8M | 4.88M | 6.4M | 7.42M | 5.66M | 6.12M | 4.09M | 1.11M | 4.19M | 4.82M | 5.25M |
| Research and Development Revenue Growth | -1.53% | -12.09% | -16.61% | +58.29% | -3.30% | +1.58% | +3.59% | -71.49% | +252.93% | -8.82% | -13.83% | +80.43% | -3.54% | -19.92% | +39.84% | +5.86% | +33.44% | -4.99% | +0.36% | +16.23% | -18.79% | -1.80% | -5.93% | -9.63% | -7.49% | +19.19% | +54.30% | +11.32% | -18.82% | -35.08% | +39.36% | -23.78% | -13.72% | +31.15% | -7.59% | +49.84% | +267.54% | -73.44% | -13.15% | -8.21% | n/a |